Introduction {#sec1-1}
============

Goal-directed therapy is the basis of any hemodynamic intervention in intensive care medicine to improve postoperative outcome.\[[@ref1][@ref2]\] This approach is based on optimizing parameters such as stroke volume, cardiac output (CO), cardiac index (CI), and/or perfusion parameters such as stroke volume variation, central venous oxygen saturation (ScvO~2~), mixed venous oxygen saturation (SvO~2~), and arterial lactate.\[[@ref1]\]

SvO~2~ is a measurement of global tissue oxygenation and it reflects matching between arterial oxygen delivery (DO~2~) and O~2~ consumption (VO~2~).\[[@ref3]\] A low SvO~2~ indicates high oxygen extraction ratio (OER) to maintain aerobic metabolism with constant O~2~ consumption in response to an acute fall in DO~2~. But when DO~2~ is below critical level, OER is no longer capable of upholding O~2~ consumption, and global tissue hypoxia ensues, as indicated by the high lactate levels.\[[@ref4][@ref5]\]

ScvO~2~ can be obtained easily and trends in ScvO~2~ closely mirrors SvO~2~.\[[@ref6]\] Cardiac surgery induces ischemia-reperfusion injury along with systemic inflammatory response leading to capillary shunting and mitochondrial damage.\[[@ref7]\] These changes cause disturbances in tissue oxygen extraction and leads to normal/high ScvO~2~ values. ScvO~2~ is measured downstream from the tissues, So, Low venous O~2~ saturation from tissue with inadequate DO~2~ is masked by highly saturated blood from tissue with better perfusion resulting overall normal or high ScvO~2~ and remaining blind to local perfusion disturbances.\[[@ref8]\]

Impaired tissue oxygenation leads to increased anaerobic metabolism and production of pyruvate, which is subsequently converted to lactate. Serum lactate is a marker of global tissue hypoxia in circulatory shock. Hyperlactatemia in cardiac surgery may be due to other mechanisms such as stress response to surgery, use of βadrenergic agonist, sepsis, hyperglycaemia etc.\[[@ref9][@ref10]\] Therefore, after cardiac surgery, hyperlactatemia may not be a reliable means of judging the adequacy of tissue oxygenation.

According to the modified Fick equation central venous-arterial pCO~2~ difference (dCO~2~) is related to CO~2~ production (VCO~2~) and inversely linked to cardiac output.\[[@ref11]\] As per Ariza *et al*.,\[[@ref12]\] better approximation of PaCO~2~ under normal condition of cardiac output and arterial oxygen saturation is PaCO~2~ = 0.8 PvCO~2~. The major determinant of increased dCO~2~ is decreased tissue perfusion. So dCO~2~ can be considered as an indicator of adequate blood flow to remove CO~2~. Its usefulness has already been described in septic shock, high risk surgical patients and on pump cardiac surgical procedures.\[[@ref1][@ref2]\] The aim of this study was to evaluate the patient outcome and clinical parameters in correlation with central venous-arterial PCO~2~ difference (dCO~2~) in cardiac surgery patients with assumed adequate circulatory status according to existing guidelines (i.e., ScvO~2~ ≥70%).

Methods {#sec1-2}
=======

After getting ethical committee approval and preoperative written and informed consent, 100 patients scheduled for elective off-pump CABG surgery were included in the study. In this prospective observational study, we evaluated the central venous to arterial PCO~2~ difference (dCO~2~) in patients with a central venous saturation (ScvO~2~) ≥70% and its relationship to the postoperative hemodynamic profile, outcome and complications.

Inclusion criteria were written informed consent, age \>18 and \<75 years, elective off-pump coronary artery bypass graft surgery, preoperative hemoglobin ≥10 g/dl and American Society of Anaesthesiology (ASA) Grade 1 and 2. Exclusion criteria were left ventricular ejection fraction of less than 35%, unstable angina pectoris, heart failure with New York Heart Association class III-IV, acute myocardial infarction within the last 2 weeks, previous CABG surgery, peripheral arterial occlusive disease and Patients with chronic obstructive pulmonary disease.

Perioperative patient management was standard, based on institutional protocol. Induction and maintenance of anesthesia was done with midazolam, fentanyl, propofol, vecuronium and sevoflurane. The right internal jugular vein was cannulated with 8.5 F Introducer sheath (IntroFlex, Edwards Lifesciences, Irvine, CA). A Swan-Ganz Thermodilution Venous Infusion Port Catheter, 7.5 F×110 CM (Edwards Lifesciences, Irvine, CA) inserted through the sheath and guided to the pulmonary artery before starting the operation. During surgery, the patients were mechanically ventilated and ETCO~2~ was maintained between 35-40 mmHg. Intraoperative fluid management was done according to goal directed fluid therapy targeting goal of maintaining mean arterial pressure ≥65 mmhg and ScvO~2~ ≥70%.

All hemodynamic and laboratory parameters were measured after surgery at 1, 6, and 18 hours after admission to the ICU. At these time points, arterial and central venous, and mixed venous blood samples were taken. The blood gas analysis was performed. We collected ScvO~2~, SvO~2~, PO~2~, SaO~2~, PCO~2~ and lactate from this analysis. Oxygen delivery index (DO~2~I), oxygen consumption index (VO~2~I), arterial oxygen content (CaO~2~), venous oxygen content (CvO~2~) and oxygen extraction ratio (OER) were calculated using standard formulae \[[ANNEXURE](#App1){ref-type="app"}\].

The dCO~2~ was calculated as the difference between the PCO~2~ of central venous and arterial blood. Based on the first measurement of dCO~2,~ the patients were divided in to two groups, the high dCO~2~ group (Group A, dCO~2~ \>8 mmHg) and the low dCO~2~ group (Group B, dCO~2~ ≤8 mmhg).

Cardiovascular complications were defined as new arrhythmias or a newly diagnosed myocardial ischemia detected in the electrocardiogram (new Q-wave, ST-elevations \>2 mm), or a ratio of creatine kinase (CK) and its myocardial subtype (CK-MB) \>10%. Neurologic complications were defined as transitory ischemic attack and postoperative delirium; pulmonary complications defined as respiratory failure and the need for reintubation, prolonged Respiratory support (\>48 h) or the need for continuous positive airway pressure breathing; renal complications were defined as patients requiring renal replacement therapy and continuous intravenous loop diuretics or patients with an increase of creatinine \>2.0 mg/dl. Additional outcome parameters like hours of mechanical ventilation, length of ICU stay, length of hospital stay and any morbidity or mortality were recorded.

Statistics {#sec2-1}
----------

Statistical analysis was performed using SPSS, Version 20.0 (Chicago, IL, USA).

The Chi-square test was used to compare the categorial variable. The independent sample *t*-test was used to compare continuous variables. Mann-Whitney U test was used where the assumptions of the *t*-test were not met. Data were presented as mean ± SD or proportion as appropriate. The "*P*" value less than 0.05 was considered to be significant.

Results {#sec1-3}
=======

A total of 100 patient undergoing elective coronary artery bypass grafting without cardiopulmonary bypass were included in our study. On admission to ICU, central venous and arterial blood gas samples were collected in all patients and analyzed. From those 100 patients, 65 patients had ScvO~2~ ≥70%. From those 65 patients, as per the first postoperative dCO~2~ measurement, 20 patients were assigned to the high dCO~2~ group (Group A, dCO~2~ \>8 mmHg) and 45 patients were assigned to low dCO~2~ group (Group B, dCO~2~ ≤8).

Demographic and clinical data of both the groups are summarized in [Table 1](#T1){ref-type="table"}. There were no differences between the basic characteristics of patients with high dCO~2~ and low dCO~2~ group. Surgery duration was comparable in both the groups. Pre-operative ejection fraction was lower in group A but the difference was not significant.

###### 

Demographic data

                     Group A (*n*=20)   Group B (*n*=45)   *P*
  ------------------ ------------------ ------------------ --------
  Age                62.2±7.31          62.4±7.17          0.9182
  Sex (M/F)          11/9               26/19              
  Height             162.95±7.40        163.93±8.36        0.6525
  Weight             66.4±10.32         66.84±11.20        0.881
  BSA                1.71±0.13          1.72±0.14          0.7860
  BMI                25.13±4.36         24.98±4.54         0.9010
  preop_pco2         33.95±6.83         35.73±4.43         0.2101
  preop_po2          82.95±9.25         85.17±8.36         0.3413
  surgery duration   290.25±70.97       298.33±61.72       0.6433
  EF                 50.50±6.66         53.3±6.82          0.1289
  DM (n)             8                  10                 0.1402
  HTN (n)            4                  06                 0.4901

Comparison of hemodynamic parameters is shown in Tables [2a](#T2){ref-type="table"} and [2b](#T3){ref-type="table"}. Heart rate (HR), mean arterial pressure (MAP), mean pulmonary artery pressure (MPA), central venous pressure (CVP), lactate, cardiac output (CO), cardiac index (CI), systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were observed at 1^st^, 6^th^ and 18^th^ hours of ICU stay in both the groups. After ICU admission, patients in group A showed an initial tendency towards lower CO, but it was not significant. However, group A had higher HR at 6^th^ and 18^th^ hour duration and were statistically significant. Patients had comparable inotropic scores at 1^st^ hour after admission to the intensive care unit. However, these values were higher at 6^th^ and 18^th^ hour in the high dCO~2~ group.

###### 

Comparision of hemodynamic parameters in patients with ScvO~2~ ≥70%

  Parameters        Time            Group A (*n*=20)   Group B (*n*=45)   *P*
  ----------------- --------------- ------------------ ------------------ --------
  HR                1^st^ hr ICU    91.35±17.76        89.77±13.11        0.6914
                    6^th^ hr ICU    85.15±9.83         78.53±12.80        0.0441
                    18^th^ hr ICU   92.85±12.35        70.42±11.86        0.001
  MAP               1^st^ hr ICU    73.5±12.23         77.75±12.23        0.2001
                    6^th^ hr ICU    70.35±9.91         83±8.85            0.001
                    18^th^ hr ICU   78.4±11.05         78.51±7.53         0.9624
  MPA               1^St^ hr ICU    35.55±6.34         27.26±4.51         0.001
                    6^th^ hr ICU    32.65±5.40         22.86±4.78         0.001
                    18^th^ hr ICU   29±4.88            18.4±3.91          0.001
  CVP               1^st^ hr ICU    12.6±1.95          9.11±1.41          0.001
                    6^th^ hr ICU    10.65±2.27         7.51±1.84          0.001
                    18^th^ hr ICU   9.2±2.74           4.24±1.89          0.001
  LACTATE           1^st^ hr ICU    3.63±2.26          2.78±1.16          0.04
                    6^th^ hr ICU    3.46±2.21          2.41±1.20          0.015
                    18^th^ hr ICU   2.48±1.02          1.64±1.08          0.004
  INOTROPIC SCORE   1^st^ hr ICU    4.93±3.38          3.11±3.93          0.077
                    6^th^ hr ICU    4.55±2.43          1.93±2.12          0.001
                    18^th^ hr ICU   2.25±2.29          0.8±1.54           0.004

###### 

Comparision of hemodynamic parameters in patients with ScvO~2~ ≥70%

  Parameters   Time            Group A (*n*=20)   Group B (*n*=45)   *P*
  ------------ --------------- ------------------ ------------------ ---------
  CO           1^st^ hr ICU    3.85±0.61          4.04±0.58          0.2462
               6^th^ hr ICU    3.93±0.53          3.96±0.54          0.8279
               18^th^ hr ICU   4±0.36             4.02±0.60          0.8942
  CI           1^st^ hr ICU    2.27±0.45          2.36±0.43          0.4427
               6^th^ hr ICU    2.31±0.41          2.30±0.32          0.9197
               18^th^ hr ICU   2.34±0.30          2.35±0.38          0.9123
  SVR          1^st^ hr ICU    1290.65±310.02     1387.6±325.09      0.03062
               6^th^ hr ICU    1230.2±217.9       1552.24±290.20     \<0.001
               18^th^ hr ICU   1379±222.5         1513.11±301.3      0.0794
  PVR          1^st^ hr ICU    323.1±174.4        247.8±65.27        0.0135
               6^th^ hr ICU    302.75±122.18      252.42±61.79       0.0306
               18^th^ hr ICU   228.1±77.64        197.95±51.51       0.0688

MAP was higher on admission in group B, but this difference was narrowed at the end of 18^th^ hour. Both CVP and MPA were significantly higher in group A at all points of measurements. SVR was higher in group B on admission to ICU whereas PVR was higher in group A which was statistically significant. Lactate levels were higher in group A and remained elevated at 6^th^ and 18^th^ hour time period as compared to group B.

Oximetry parameters are listed in [Table 3](#T4){ref-type="table"}. We did the arterial, venous and mixed venous blood gas analysis and calculated arterial oxygen content (CaO~2~), mixed venous oxygen content (CvO~2~), oxygen delivery index (DO~2~I), oxygen consumption index (VO~2~I) and oxygen extraction rate (OER) at 1^st^, 6^th^ and 18^th^ hours of ICU stay in both the groups. The CaO~2~ 1^st^ hour after ICU admission was significantly lower in group A, but was within physiological limit (*P* \< 0.05). Gradually CaO~2~ improved over time and showed no difference at 18^th^ hour after ICU admission. Similarly, DO~2~I was also lower in group A on admission and remained lower than group B at all point of time but the difference was not significant. While comparing the CvO~2~, it was significantly lower in group A at 1^st^ hour after ICU admission and remained lower at 18^th^ hour. OER was significantly higher in group A as compared to group B at 1^st^ hour. VO~2~I did not show a significant difference.

###### 

Comparision of oximetry parameters in patients with ScvO~2~ ≥70%

  Parameters   Time            Group A (*n*=20)   Group B (*n*=45)   *P*
  ------------ --------------- ------------------ ------------------ ---------
  ScvO~2~      1^st^ hr ICU    75.3±3.55          74.84±3.64         0.6409
               6^th^ hr ICU    71.35±4.86         72.35±4.04         0.3883
               18^th^ hr ICU   70.6±4.61          71.4±3.51          0.4456
  SvO~2~       1^st^ hr ICU    67.3±7.16          72.86±4.71         \<0.001
               6^th^ hr ICU    66.65±6.82         68.02±4.91         0.3619
               18^th^ hr ICU   67.45±6.10         69.2±4.19          0.1842
  CaO~2~       1^st^ hr ICU    13.32±1.67         15.05±2.09         0.0017
               6^th^ hr ICU    13.48±0.89         13.62±1.92         0.7513
               18^th^ hr ICU   13.47±1.42         13.56±1.18         0.791
  CvO~2~       1^st^ hr ICU    9.1±1.61           10.95±1.63         \<0.001
               6^th^ hr ICU    9.35±1.26          9.48±1.68          0.7435
               18^th^ hr ICU   9.34±1.17          9.73±0.98          0.1654
  DO~2~I       1^st^ hr ICU    299.76±72.36       355.84±78.9        0.0082
               6^th^ hr ICU    309.28±64.13       315.75±68.29       0.7201
               18^th^ hr ICU   317.98±65.84       318.95±60.8        0.950
  VO~2~I       1^st^ hr ICU    98.35±31.71        95.48±27.13        0.7109
               6^th^ hr ICU    102.15±39.2        95.3±26.0          0.4124
               18^th^ hr ICU   101.1±32.12        92.55±26.08        0.2612
  OER          1^st^ hr ICU    0.323±0.07         0.269±0.049        \<0.001
               6^th^ hr ICU    0.314±0.075        0.302±0.05         0.4495
               18^th^ hr ICU   0.304±0.065        0.287±0.047        0.2378

Post-operative outcome parameters are listed in [Table 4](#T5){ref-type="table"}. The observed hemodynamic, oximetric and laboratory alterations were associated with a significantly prolonged need for mechanical ventilation (14.90 ± 10.33 vs 10 ± 9.65 hrs, *P* = 0.04) and ICU stay (5.05 ± 2.52 vs 3.75 ± 2.36 days, *P* = 0.049) in group A. Incidence of re-exploration was similar in both the groups. The total duration of hospital stay was significantly higher in group A. In the high dCO~2~ group, out of 20 patients, one patient died due to multi-organ failure and septic shock, while in the low dCO~2~ group, out of 45 patients, one patient died due to respiratory failure and sepsis.

###### 

Comparison of outcome parameters in patients with ScvO~2~ ≥70%

                                       Group A (*n*=20)   Group B (*n*=45)   *P*
  ------------------------------------ ------------------ ------------------ --------
  Duration of mechanical ventilation   14.90±10.33        10±9.65            0.0402
  ICU STAY                             5.05±2.52          3.75±2.36          0.049
  HOSPITAL STAY                        12.25±5.90         8.57±5.55          0.018
  REEXPLORATION (*n*)                  1                  1                  0.54
  COMPLICATIONS (*n*)                  1                  1                  0.54

Discussion {#sec1-4}
==========

After cardiac surgery, the patient might be subjected to undetected tissue hypoperfusion even when circulation and oxygen supply/demand ratio is considered adequate by ScvO~2~ ≥70%. Here in our study, we found that in cardiac surgery patients, dCO~2~ may be used as an additional, readily available tool to identify clinically relevant hypoperfusion. Current techniques for monitoring tissue perfusion have largely focused on systemic blood flow and the balance between oxygen demand and supply.\[[@ref13]\] An early hemodynamic optimization that targets central venous oxygen saturation (ScvO~2~) and systemic hemodynamic parameters improves outcomes in severe sepsis and septic shock, reinforcing the idea that tissue perfusion abnormalities are flow dependent at least during the very early stages.\[[@ref14]\] A ScvO~2~ ≥70% is considered a goal for optimal hemodynamic resuscitation after cardiac surgery according to the S3 guidelines for postoperative intensive care in cardiac surgery patients, and also in the Surviving Sepsis Guidelines.\[[@ref2]\] However, normalizing systemic hemodynamic parameters does not guarantee adequate tissue perfusion, and in fact a substantial number of patients still progress to multiorgan dysfunction and death despite meeting ScvO~2~ targets.\[[@ref14]\]

In our study, we found low CI, low MAP and higher HR in the high dCO~2~ group. These findings are in line with the study done by Futier *et al*.\[[@ref15]\] They concluded that ScvO~2~ reflects important changes in O~2~ delivery in relation to O~2~ needs during the perioperative period. A dCO~2~ \<5 mmHg might serve as a complementary target to ScvO~2~ during goal-directed therapy to identify persistent inadequacy of the circulatory response in face of metabolic requirements when a ScvO~2~ ≥70% is achieved. A recently published study reported a higher prevalence of circulatory shock in patients with a pre-operatively increased dCO~2~.\[[@ref16]\]

We found higher lactate levels in the high dCO~2~ group on admission to ICU and this difference persisted at 6^th^ and 18^th^ after ICU admission also. Similar results were observed by Vallee *et al*.\[[@ref17]\] The study reported that the low dCO~2~ group had a lower (Simplified Acute Physiology Score) SOFA score after 24 hours, despite the fact that they had a higher score at admission to the ICU. Furthermore, a significantly lower lactate level was described for the low dCO~2~ group. The authors concluded that a high dCO~2~ can identify patients who are still under-resuscitated, even when they are resuscitated to a ScvO~2~ ≥70 according to the surviving sepsis campaign guideline.\[[@ref17]\] In another study by Bakker *et al*.,\[[@ref18]\] septic patients showed that a high dCO~2~ was associated with poor outcome and higher lactate levels.

There are many reasons for a high dCO~2~. It has been shown that dCO~2~ was related linearly to CO~2~ production and inversely related to cardiac output.\[[@ref19]\] Several studies showed that if global or regional blood flow was critically reduced or unevenly distributed as in shock, venous blood carbon dioxide increased.\[[@ref20][@ref21]\] Therefore, dCO~2~ may increase after hypoperfusion because of a decreased washout.\[[@ref22]\] Thus, dCO~2~ also has been proposed as a marker of tissue hypoxia.\[[@ref23]\] Durkin *et al*.\[[@ref24]\] described 2 different mechanisms for increased dCO~2~ in patients suffering from shock. The first mechanism was related to the lower blood flow in shock patients. A longer blood transit time in the microcirculation because of decreased microcirculatory flow causes more carbon dioxide to diffuse in to venous blood. Secondly, because of the increased ventilation-to-perfusion ratio, arterial partial pressure of carbon dioxide decreases as well. Another possible mechanism is a relative increase in carbon dioxide production by ischemic cells through anaerobic metabolism, which would explain the relative increase of venous-to-arterial partial pressure of carbon dioxide.\[[@ref24][@ref25]\]

In our study, CI and DO~2~ were lower in the high dCO~2~ group. We also found that OER was significantly higher in the high dCO~2~ group. This was in line with the results described by Durkin *et al*.,\[[@ref24]\] for example, related to microcirculatory hypoperfusion in the hepatosplanchnic region. Therefore, the results could be interpreted as insufficient tissue perfusion with lactic acidosis due to anaerobic metabolism. A relationship between a high dCO~2~ (9 mmHg ± 0.5 mmHg) and lactate levels was described in an earlier investigation in postoperative cardiac surgical patients.\[[@ref12]\] Other studies reported a correlation between dCO~2~ and CI.\[[@ref26][@ref27]\]

Our study showed high VO~2~I and high OER in the high dCO~2~ group. These results in low SvO2 values as compare to ScvO2 potentially because of splanchnic hypoperfusion. This was also in line with data from Nygren *et al*.,\[[@ref28]\] who showed that patients with intestinal vasoconstriction and hypoperfusion had significantly lower SvO~2~ compared to patients with normal intestinal perfusion after cardiac surgery. This was supported by the finding that after hemodynamic deterioration mesenteric blood flow decreased, resulting in venous desaturation of the lower body.\[[@ref29]\] Therefore, it seemed quite reasonable to assume splanchnic hypoperfusion in the patients with a high dCO~2~ gap. Splanchnic hypoperfusion in the high dCO~2~ group also was supported by the increase of the aspartate transaminase (SGOT) on day 1 pointing towards structural liver damage.

Clinically, patients with high dCO~2~ required longer ICU stay, mechanical ventilation, and had a higher incidence of cardiovascular complications in the postoperative setting. Therefore, we believe that a substantial cohort of cardiac surgical patients in the postoperative period might have been under-resuscitated if ScvO~2~ ≥70% alone was used as the goal to assess the adequacy of global and microcirculatory perfusion. Du *et al*. had also confirmed these findings.\[[@ref30]\] Thus, from a physiologic point of view, it seemed reasonable to assume that hemodynamic optimization strategies minimizing dCO~2~ aiming at individualized increases of global and regional/splanchnic blood flow to adjust for individual carbon dioxide production might have been more sufficient compared to strategies aiming solely at ScvO~2~ ≥70%.

Conclusion {#sec1-5}
==========

The present study demonstrates dCO~2~ as an easy to assess and routinely available tool to detect global and microcirculatory hypoperfusion in post-operative off-pump CABG patients, with assumed adequate fluid status and ScvO~2~ as a hemodynamic goal. We observed that high dCO~2~ (\>8 mmHg) was associated with decreased DO~2~I, increased oxygen extraction ratio, increased postoperative complication rate, the longer need for mechanical ventilation and longer ICU stay. This suggest that a high dCO~2~ is associated with microcirculatory hypoperfusion and might be a useful marker to detect patients who remain insufficiently resuscitated and it can better guide volume management in the post off-pump CABG patients and decrease the mechanical ventilation time and length of ICU stay. However, we admit that more prospective studies testing this hypothesis and the finding reported here are needed.
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**Calculation formulas**

**Cardiac index** (L/min/m^2^)

 CI = CO/ BSA(m^2^)

 CI, cardiac index; CO, cardiac output

**Oxygen delivery** (mL/min/m^2^)

 DO~2~I = CaO~2~ × CI × 10

 DO~2~I, oxygen delivery; CaO2, arterial oxygen content; CI, cardiac index

**Oxygen consumption (mL/min/m^2^)**

 VO~2~I = (CaO~2~ -- CvO~2~) × CI × 10

 VO~2~I, oxygen consumption; CaO~2~, arterial oxygen content; CvO~2~, oxygen content; CI cardiac index

**Arterial oxygen content** (mL/dL)

 CaO~2~ = (Hb × 1.39 × SaO~2~) + (0.0031 × paO~2~)

 CaO~2~ arterial oxygen content; Hb, hemoglobin concentration; SaO~2~, arterial oxygen saturation; paO~2~, arterial partial pressure of oxygen: 1.39 is the oxygen-carrying capacity of hemoglobin (mL O~2~/ gram Hb); 0.0031 is the solubility coefficient of oxygen in plasma (mL O~2~/mmHg pO~2~)

**Mixed venous oxygen content** (mL/dL)

 CvO~2~ = (Hb × 1.39 × SvO~2~) + (0.0031 × pvO~2~)

 CvO~2~, mixed venous oxygen content; Hb, hemoglobin concentration; SvO~2~, mixed venous oxygen saturation; pvO~2~, mixed venous partial pressure of oxygen

**Oxygen extraction rate (%)**

 OER = VO~2~I/DO~2~I

 VO~2~I, oxygen consumption; DO~2~I, oxygen delivery
